Scientific and Medical Advisors


Management Team
 

Elena Aikawa, MD, PhD is an Associate Professor of Medicine at Harvard Medical School and a Principle Investigator at the Center for Excellence in Vascular Biology, and Director of the Heart Valve Translational Research Program at Brigham and Women’s Hospital, Boston, MA, USA. Dr. Aikawa is a member of the National Heart, Lung, and Blood Institute (NHLBI) Working Group on Calcific Aortic Valve Stenosis and the Alliance of Investigators on Calcific Aortic Valve Disease. She is an Editorial Board Member of Arteriosclerosis, Thrombosis and Vascular Biology, PLoS ONE, Journal of Extracellular Vesicles, and Circulation Research.

 
 
Management Team
 

Stephen Badylak, DVM, PhD, MD is a Professor in the Department of Surgery, and deputy director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. Dr. Badylak holds over 50 U.S. patents, 200 patents worldwide, has authored more than 300 scientific publications and 40 book chapters, and has edited a textbook entitled “Host Response to Biomaterials”. He has served as the Chair of several study sections at the National Institutes of Health (NIH), and is currently a member of the College of Scientific Reviewers for NIH. More than six million patients have been treated with bioscaffolds developed in Dr. Badylak’s laboratory. Dr. Badylak is a past president of the Tissue Engineering Regenerative Medicine International Society (TERMIS) and a Founding International Fellow of TERMIS.

 
 
Management Team
 

Krzysztof Bartus, MD, PhD is Associate Professor at Jagiellonian University, Senior Research Assistant Professor at Jagiellonian University, Krakow, Poland. He is a cardiac surgeon practicing at John Paul II Hospital in Krakow as well as University Hospital in Krakow. He has also been Investigator, Co-Investigator and Clinical Study Coordinator in 60+ FDA controlled clinical trials in the fields of Interventional Cardiology, Cardiac Surgery, and numerous other fields. He performed 16 first in man studies with different medical devices in cardiovascular field.

 
 
Management Team
 

Kelvin Brockbank, PhD is a consultant with Neograft. He is the CEO of Tissue Testing Technologies LLC, Research Professor of Bioengineering at Clemson University, and Adjunct Professor, Dept. of Regenerative Medicine and Cell Biology at the Medical University of South Carolina. Dr. Brockbank has more than twenty five years of project management experience and is credited with more than 450 publications, patents and presentations.

 
 
Management Team
 

Arthur J. Coury, PhD is currently an industry consultant and academic professor. His career focus has been polymeric biomaterials for medical products such as implantable electronic devices, hydrogel-based devices and drug delivery systems. His industrial experience includes Director, Polymer Technology and Research Fellow at Medtronic, Inc., Vice President, Research and Chief Scientific Officer at Focal, Inc., and Vice President, Biomaterials Research at Genzyme Corporation.

He holds over fifty five distinct patents, has published and presented widely in his field, and is a member of numerous university, professional society and corporate advisory boards.

 
Management Team
 

Robert Dowling, MD serves as Neograft’s Medical Director. Rob received his training in General Surgery and Cardiothoracic surgery at the University of Pittsburgh Medical Center. He was a Professor of Surgery at University of Louisville where he served as Director of the Adult and Pediatric Heart Transplant Programs and Director of Mechanical Circulatory Support. He has been involved in many clinical trials in adult cardiac surgery including multiple trials of circulatory support devices. He has extensive experience with preclinical device development and design of clinical trials. Dr. Dowling led the team that performed the first implants of the AbioCor Implantable Replacement Heart.  Dr. Dowling serves as an advisor to several other companies in the field and is a widely recognized expert on the surgical treatment for heart failure and adult cardiac surgery. He is widely published and is a frequent speaker at professional society meetings.

 
Management Team
 

Elazer R. Edelman, MD, PhD is the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at MIT, Professor of Medicine at Harvard Medical School, and Senior Physician in the Cardiac Care Unit at BWH. Dr. Edelman directs the Harvard‐MIT Biomedical Engineering Center. He is very widely published, has mentored more than 300 students and fellows and as Fellow of many of the National Academies and Chief Science Advisor of Science Transnational Medicine has helped direct public health policy.

 
 
Management Team
 

Howard Greisler, MD has been Professor of Surgery and of Cell Biology, Neurobiology and Anatomy at Loyola University Medical Center and vascular surgeon at both Loyola and at Hines VA Hospital. He has conducted many research projects on cardiovascular devices, myointimal hyperplasia, angiogenesis and tissue engineering. He is a founding member and five time past president of the International Society of Applied Cardiovascular Biology and an enthusiast of Bonsai horticulture.

 

 
 
Management Team
 

Mike Helmus, PhD Medical Devices, Drug Delivery, NanoTechnology, Tissue Engineering, is a biomaterials expert consultant with Neograft. Dr. Helmus has over three decades of experience managing medical device R&D. His involvement with medical devices includes drug eluting stents and coatings, large and small diameter vascular grafts, mechanical and biologic heart valves and wound dressings. Dr. Helmus is an inventor on 44 issued US patents and is widely published in peer reviewed journals.

 
 
Management Team
 

Gary S. Mintz, MD is Chief Medical Officer of the Cardiovascular Research Foundation, Editor-in-Chief of TCTMD.com, and the Managing Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). Dr. Mintz has extensive experience in both interventional cardiology and cardiovascular imaging, in particular intravascular imaging and physiology. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program that has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University, in 1974, both in Philadelphia, PA.

 
 
Management Team
 

Alejandro Nieponice, MD, PhD is currently the Director of the Esophageal Institute at Hospital Universitario Fundación Favaloro in Buenos Aires, Argentina. He is also a faculty member of the McGowan Institute for Regenerative Medicine and an Adjunct Research Assistant Professor of the Department of Surgery at the University of Pittsburgh. Dr. Nieponice got his MD and PhD degrees at the University of Buenos Aires. He joined the McGowan Institute for Regenerative Medicine in 2004. Prior to that, he completed the general surgery residency program in Argentina with a focus on esophageal surgery. Dr. Nieponice is conducting research with biomaterials to improve healing of gastrointestinal tissue with the aim of decreasing surgical complications. He is currently a member of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the Argentinean Surgical Society (MAAC).

 
 
Management Team
 

Frederick Schoen, MD, PhD is a cardiovascular pathologist/biomedical engineer with current activities across the broad academic spectrum of patient care, research, teaching and administration. He served as Director of Cardiac Pathology at BWH for over 30 years (1980-2013) and has served as Vice Chairman in the BWH Department of Pathology since 1991. He is author or co-author of over 470 manuscripts cardiovascular pathology, biomaterials and medical devices in journals and books and an author/editor of leading books in those areas.

 
 
Management Team
 

Toshiharu Shinoka, MD, PhD is Co-Director of the Tissue Engineering Program at Nationwide Children’s Hospital. His clinical and research interests center on bioengineered tissue for use in surgery. He was the first in the world to tissue engineer blood vessels and implant them in human infants. Dr. Shinoka has many honors recognizing his contributions to the field of regenerative medicine.

 
 
Management Team
 

Serge Rousselle, DVM is a veterinary pathologist with 20+ years of experience in preclinical histopathology. He co-founded a specialty histopathology laboratory (Alizée Pathology) with a technical platform optimized for the assessment of implants and devices in preclinical studies. His areas of specialty include medical devices, general toxicology, carcinogenicity in conventional and genetically modified rodents, and investigative pathology. He is generally recognized for his expertise in cardiovascular pathology.

 
 
Management Team
 

Gregory C. Rutledge, PhD is the Lammot du Pont Professor of Chemical Engineering at MIT, and former Director of the Program in Polymer Science and Technology and Executive Officer of the Department of Chemical Engineering at MIT. He is a Fellow of the American Physical Society and of the Polymer Materials Science and Engineering Division of the American Chemical Society, and a recipient of The Founders Award of the Fiber Society. He is an Editor for the Journal of Materials Science and serves on several other editorial boards. His research on polymer science and engineering focuses on understanding properties and processing of polymeric materials based on knowledge of their chemistry and molecular level structure. His processing expertise includes electrospinning.

 
 
Management Team
 

Peter Zilla, MD, PhD is the incumbent of the Chris Barnard Chair at the University of Cape Town, he is the Director of UCT’s Cardiovascular Research Unit. His background as both basic scientist and heart surgeon is reflected in two MDs, one PhD and one PD degree from the Universities of Vienna (Austria), Zurich (Switzerland) and Cape Town (South Africa) as well as four surgical specialist qualifications in Europe and South Africa and 21 international patents for implantable cardiovascular devices. He is the Head of the Department of Cardiothoracic Surgery at Groote Schuur Hospital and at Red Cross Children’s Hospital.